Retatrutide Pen 20mg (R&D Only) is presented strictly as a research-use product for qualified laboratory and scientific research applications. Retatrutide is an investigational triple hormone receptor agonist being studied for its activity at GIP, GLP-1 and glucagon receptors.

This product is not authorised for human use in the UK and should not be represented as a prescription medicine, weight-loss treatment or consumer medication. The stated 20mg designation refers to the product specification supplied by the vendor and should be verified against the applicable product documentation, certificate of analysis and batch information before use in any legitimate research setting.